Previous studies have demonstrated that inhibition of the PI3K/Akt pathway diminishes Cyclin B1 and CDK1 expression levels, thereby leading to the arrest of CC cells and bladder cancer cells in the G2/M phase (Wang et al., 2017; Bhosale et al., 2021). The gene discussed is CDK1; the disease is urinary bladder carcinoma.